59 results
PRE 14A
IXHL
Incannex Healthcare Limited
31 Oct 24
Preliminary proxy
4:10pm
policies relating to compensation and benefits of our officers and employees. The compensation committee approves corporate goals and objectives relevant … , and also does not include Australian post-employment benefits.
This amount does not include Australian post-employment benefits.
Dr. Barbato
8-K
EX-99.1
IXHL
Incannex Healthcare Limited
24 Oct 24
Incannex Announces Appointment of Dr. Lou Barbato as Chief Medical Officer
7:30am
of these trials, and the potential benefits, safety or of Incannex’s drug candidates. Forward-looking statements are statements other than historical facts
8-K
EX-10.1
IXHL
Incannex Healthcare Limited
24 Oct 24
Departure of Directors or Certain Officers
7:01am
of employment.
(e) Fringe Benefits. Employee shall be entitled to participate in any benefit/welfare plans and fringe benefits the Company decides … to provide for its senior executives. Employee understands that, except when prohibited by applicable law, the Company’s benefit plans and fringe benefits
8-K
EX-10.2
IXHL
Incannex Healthcare Limited
21 Oct 24
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
4:35pm
the covenants or the performance of this Debenture, and the Company (to the extent it may lawfully do so) hereby expressly waives all benefits or advantage
8-K
EX-10.1
IXHL
Incannex Healthcare Limited
15 Oct 24
Entry into a Material Definitive Agreement
3:54pm
:
(a) the right, title and interest of an Obligor in all money, dividends, dividend investment schemes, bonus issues, rights issues, allotments, offers, benefits … and accurate; and
(ii)
will receive reasonable commercial benefits by reason of the execution and delivery of the Transaction Documents to which it is a party
8-K
EX-99.1
5r2y4eocmbx7fyik
30 Sep 24
Incannex Healthcare Inc. Reports Fiscal Full Year 2024 Financial Results and Business Updates
4:01pm
10-K
EX-10.9
86no x8lz4ikx2
30 Sep 24
Annual report
7:30am
10-K
hvi8iw38dg6ke9uu2
30 Sep 24
Annual report
7:30am
8-K
EX-10.1
yy9eun mhjiwy
10 Sep 24
Entry into a Material Definitive Agreement
7:30am
8-K
EX-10.2
6yqbfkhc fz4wlnwc7
10 Sep 24
Entry into a Material Definitive Agreement
7:30am
S-1/A
wdnlnyev8b e2
17 Jul 24
IPO registration (amended)
8:47am
S-1/A
EX-10.10
8jqdm dlwyzj75l9yf5h
17 Jul 24
IPO registration (amended)
8:47am
S-1/A
EX-10.9
iuanlorfx4rnweddb
17 Jul 24
IPO registration (amended)
8:47am
S-1
3jobn
3 Jul 24
IPO registration
6:29am
8-K
EX-99.1
3yy3p os6ci
7 May 24
Incannex Complete Successful Pre-IND Meeting with the FDA for CannQuit-O for treatment of opioid use disorder
8:30am
10-Q
bv74mpb6ot3r28gzc4q
14 Feb 24
Quarterly report
6:16am
8-K
EX-99.1
up0 zd06fqfuaysrlfl
1 Feb 24
Other Events
7:30am
8-K
EX-10.1
cmi 6ondrv
29 Nov 23
Entry into a Material Definitive Agreement
4:36pm
8-K
EX-10.2
u81mq8csm7d006 608k
29 Nov 23
Entry into a Material Definitive Agreement
4:36pm